Home
Conditions
Lymphoma, Follicular

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Recruiting

Drinking, Acetate, and Stress

NCT06584448

Conditions: Alcohol Drinking, Alcohol Use Disorder, Alcohol Use Disorder, Moderate, in Sustained Remission, +20 more
Locations: The Anlyan Center, 300 Cedar St. New Haven, Connecticut, United States

Yale University New Haven, Connecticut, United States

View Trial Details

Recruiting

Chronic CED of TPT for Recurrent Malignant Glioma

NCT06666712

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, Recurrent, +23 more
Locations: Columbia University Irving Medical Center / NewYork-Presbyterian Hospital New York, United States

View Trial Details

Recruiting

A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

NCT06703892

Conditions: Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Follicular Lymphoma ( FL), +13 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: LLC ARENSIA Exploratory Medicine Tbilisi, Georgia

IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova

Hospital Beata Maria Ana Madrid, Spain

Hospital Fundación Jiménez Diaz Madrid, Spain

View Trial Details

Recruiting

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

NCT07558538

Conditions: ARDS (Acute Respiratory Distress Syndrome), ARDS (Moderate or Severe), Acute Lung Injury, +13 more
Locations: ShanghaiZhongshan Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma

NCT07555470

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

NCT06745583

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +23 more
Locations: Taipei Veterans General Hospital Taipei, Taiwan

Tri-Service General Hospital Taipei, Taiwan

View Trial Details

Recruiting

Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5

NCT06284122

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Krankenhaus der Barmherzigen Brüder Graz - Abteilung Für Innere Medizin I Graz, Austria

Krems University Hospital - Abteilung Für Innere Medizin 2 Krems, Austria

LKH HOCHSTEIERMARK - Department für Hämato-Onkologie Leoben, Austria

Kepler Universitaetsklinikum - Univ.-Klinik für Hämatologie und Internistische Onkologie Linz, Austria

View all 116 locations

View Trial Details

Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions: ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

NCT06948786

Conditions: Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +12 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Lymphoma, Follicular

Lymphoma, Follicular trial results

Related conditions